Skip Navigation

Open Label Phase II Study of Tisotumab Vedotin for Patients with Platinum-Resistant Ovarian Cancer with a Safety Run-in of a Dose-Dense Regimen

Brief Summary

Type:
Ovarian

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03657043

Study #:
STUDY00143494

Start Date:
Aug 04, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03657043

View Complete Trial Details & Eligibility at ClinicalTrials.gov